Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
3.580
-0.040 (-1.10%)
At close: May 15, 2025, 4:00 PM
3.600
+0.019 (0.54%)
After-hours: May 15, 2025, 7:55 PM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $243.93 million as of May 15, 2025. Its market cap has increased by 214.74% in one year.
Market Cap
243.93M
Enterprise Value
200.87M
1-Year Change
214.74%
Ranking
Category
Stock Price
$3.58
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has decreased from $290.80M to $243.93M, a decrease of -16.12%. That is a compound annual growth rate of -1.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 279.20M | -18.79% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |